On September 29, 2021, TailorMed Medical Ltd. closed the transaction. The company amended the terms of the transaction. The company will now issue $25 million in the transaction. The company raised $5 million in its final tranche. The round was led by UnityPoint Health Ventures. The new strategic investors, BrightEdge Technologies, Inc., OSF Healthcare’s corporate investment arm, OSF Ventures, Citi Impact Fund, a fund managed by Citi Ventures, Inc., Sanara Capital Fund, a fund managed by Sanara Ventures.